<DOC>
	<DOCNO>NCT01798433</DOCNO>
	<brief_summary>In patient unprotected leave main ( LM ) true bifurcation lesion ( cohort A ) , elective 2-stent strategy superior provisional strategy prevent occurrence 12-month target lesion failure percutaneous coronary intervention bifurcation lesion . In patient unprotected LM non-true bifurcation lesion ( cohort B ) , 1-stent technique mandatory final kissing ballooning superior 1-stent technique without kiss balloon prevent occurrence 12-month target lesion failure percutaneous coronary intervention bifurcation lesion .</brief_summary>
	<brief_title>STRATEGY Left Main Coronary Bifurcation Lesion II</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<criteria>1 . Age ≥20 year 2 . Left main bifurcation lesion coronary angiography 3 . Significant myocardial ischemia Main vessel ( left main coronary artery leave anterior descend artery ) and/or side branch ( left circumflex artery ) diameter stenosis &gt; 75 % , diameter stenosis 5075 % angina and/or objective evidence ischemia noninvasive stress test 4 . Significant size main branch ( left anterior descend artery ) side branch ( left cirmflex artery ) The reference diameter branch ≥ 2.5 mm visual estimation 1 . The patient know hypersensitivity contraindication follow medication : Heparin , Aspirin , Clopidogrel , Biolimus 2 . Patients receive DES implantation target lesion prior enrollment</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Angioplasty</keyword>
	<keyword>Transluminal</keyword>
	<keyword>Percutaneous Coronary</keyword>
</DOC>